{
    "title": "GSK to get $1.25 bln to settle HIV drug patent row with Gilead",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-10467349/GSK-1-25-bln-settle-HIV-drug-patent-row-Gilead.html",
    "date": "2022-02-02",
    "keywords": [
        "gsk",
        "hiv",
        "settlement",
        "viiv",
        "gilead",
        "aripaka",
        "part",
        "unit",
        "biktarvy",
        "market",
        "drugmaker",
        "longdrawn",
        "patent",
        "dispute",
        "tuesday",
        "drug",
        "medicine",
        "aidscausing",
        "virus",
        "httpswwwgskcomengbmediapressreleasesviivhealthcarefilespatentinfringementlitigationagainstgileadsciencesincoverbictegravir",
        "pfizer",
        "plan",
        "business",
        "consumer",
        "healthcare",
        "payment",
        "quarter",
        "year",
        "royalty",
        "product",
        "component",
        "profit",
        "gmt",
        "wednesday",
        "tablet",
        "challenge",
        "selling",
        "supplier",
        "dominance",
        "httpswwwgskcomengbmediapressreleasesviivhealthcareannouncesusfdaapprovalofcabenuvacabotegravirrilpivirineforuseeverytwomonthsexpandingthelabelofthefirstandonlycompletelongactinghivtreatment",
        "use",
        "viivs",
        "cabenuva",
        "injection",
        "treatment",
        "failure",
        "resistance",
        "pushkala",
        "jahnavi",
        "nidumolu",
        "bengaluru",
        "burger",
        "frankfurt",
        "editing",
        "krishna",
        "chandra",
        "eluri",
        "arun",
        "koyyur"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}